I et forsøg med aber var antallet af aborter fordoblet hos natalizumab- behandlede (30 mg/ kg) grupper i forhold til matchende kontrolgrupper.
In a study in monkeys, the number of abortions was doubled in the natalizumab 30 mg/ kg treatment groups versus matching control groups.